Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06217900 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

a PROspective Case Control Study to Develop and Validate a Blood Test FOr mUlti-caNcers Early Detection（PROFOUND）

Name: a PROspective Case Control Study to Develop and Validate a Blood Test FOr mUlti-caNcers Early Detection（PROFOUND） — clinical trial record (NCT06217900)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PROFOUND

StatusRecruiting

PhaseNot specified

SponsorShanghai Weihe Medical Laboratory Co., Ltd.

Started2023-12-28

View on ClinicalTrials.gov ↗

This study is a multi-center, case-control study aiming at developing and blinded testing machine learning-based multiple cancers early detection model by prospectively collecting blood samples from newly diagnosed cancer patients and individuals without confirmed cancer diagnosis.

Trial Details

NCT Number	NCT06217900
Lead Sponsor	Shanghai Weihe Medical Laboratory Co., Ltd. Collaborators: Peking University People's Hospital
Conditions	Cancer
Enrollment	16,666 participants
Start Date	2023-12-28
Primary Completion	2026-10-31 (estimated)
Study Completion	2027-03-31 (estimated)
Updated on ClinicalTrials.gov	2024-01-23